Sanofi's deep partnership with OpenAI could be a huge differentiating factor. Check out why I rate SNY stock a buy.

Acquired by French global healthcare giant Sanofi in 2011, Genzyme has made the security of its physical and intellectual assets a priority since the 1990s, and was among the first companies to define ...

Kuehne+Nagel supports Sanofi in multiple countries worldwide, including Hungary, the UK, and the UAE, by providing customised ...

In a major step forward, Sanofi, which signed last year an offtake agreement with Sudair Pharma Company (SPC) and NUPCO, is transferring its global expertise ... national drug security and ensure ...

Sanofi and Boehringer Ingelheim (BI), drug giants from Europe, have sought for local regulatory clearances from the Competition Commission of India (CCI), so that it can complete the global asset ...